A supplement that produces an increased feeling of alertness and reduces anxiety, or produce a feeling of calmness is described. In an exemplary embodiment, the supplement is all natural, and contains no or essentially no synthesized chemical. The supplement or the therapeutic ingredients, such as the ingredients within a capsule, may only contain plant matter. The plant matter may include plant roots and leaves, for example. The supplement and more specifically the active ingredient of the supplement may include, piper methysticum (kava kava root), brahmi (bacopa), ashwagandha (winter cherry). These three ingredients may be the primary active or therapeutic ingredients and may be provided in an effective amount to produce a feeling of alert calmness.

A supplement that produces an increased feeling of alertness and reduces anxiety, or produce a feeling of calmness is described. In an exemplary embodiment, the supplement is all natural, and contains no or essentially no synthesized chemical. The supplement or the therapeutic ingredients, such as the ingredients within a capsule, may only contain plant matter. The plant matter may include plant roots and leaves, for example. The supplement and more specifically the active ingredient of the supplement may include, piper methysticum (kava kava root), brahmi (bacopa), ashwagandha (winter cherry). These three ingredients may be the primary active or therapeutic ingredients and may be provided in an effective amount to produce a feeling of alert calmness.

A compound (3R,5S,5aS,6R,7S,8R,8aS)-8-chloro-8a-hydroxy-5-(2-hydroxy acetoxy) hexahydro-1H-3,6-methanocyclopenta[e][1,3]dioxepin-7-yl 3,4-dihydroxybenzoate (KS534), the isomer thereof, the pharmaceutically acceptable salt or solvates thereof, a composition comprising the same as an active ingredient for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease (COPD)

A compound (3R,5S,5aS,6R,7S,8R,8aS)-8-chloro-8a-hydroxy-5-(2-hydroxy acetoxy) hexahydro-1H-3,6-methanocyclopenta[e][1,3]dioxepin-7-yl 3,4-dihydroxybenzoate (KS534), the isomer thereof, the pharmaceutically acceptable salt or solvates thereof, a composition comprising the same as an active ingredient for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease (COPD)

The present invention discloses compositions comprising CBD and several herbal extract and use thereof in treatment of mental disorders such as Attention Deficit Hyperactivity disorder (ADHD) and Post Traumatic Stress Disorder (PTSD).

The present invention discloses compositions comprising CBD and several herbal extract and use thereof in treatment of mental disorders such as Attention Deficit Hyperactivity disorder (ADHD) and Post Traumatic Stress Disorder (PTSD).

The present invention discloses compositions comprising CBD and several herbal extract and use thereof in treatment of mental disorders such as Attention Deficit Hyperactivity disorder (ADHD) and Post Traumatic Stress Disorder (PTSD).

The present disclosure relates to a composition including a Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) for prevention or treatment of inflammation, allergies, and asthma The Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) is useful as a pharmaceutical composition, health functional food, or health supplement food for prevention and treatment of inflammation, allergies, and asthma due to the confirmation, through various animal experiments, that a Veronicastrum sibiricum L. Pennell (genus Veronicastrum) extract exhibits excellent anti-inflammatory, anti-allergic and asthma-inhibitory activity, the animal experiments including: evaluation of inhibition of leukotriene production (Experimental Example 1); effects on the total number of cells in bronchoalveolar lavage (BAL) fluid by using male Balb/c mice (Experimental Example 2); effects on the number of neutrophil cells relative to the total number of cells in the BAL fluid (Experimental Example 3); effects on the number of Neutrophil+/Gr-1+ absolute cells in the BAL fluid (Experimental Example 4); effects on the number of CD11b+/Gr-1+ absolute cells from among lung cells (Experimental Example 5); effects on the number of CD4+/CD3+ absolute cells from among lung cells (Experimental Example 6); effects on the number of Macrophage+/CD11b+ absolute cells from among lung cells (Experimental Example 7); effects on the expression of inflammation factors in the BAL fluid (Experimental Example 8); and the like.

The present disclosure relates to a composition including a Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) for prevention or treatment of inflammation, allergies, and asthma The Veronicastrum sibiricum L. Pennell extract (genus Veronicastrum) is useful as a pharmaceutical composition, health functional food, or health supplement food for prevention and treatment of inflammation, allergies, and asthma due to the confirmation, through various animal experiments, that a Veronicastrum sibiricum L. Pennell (genus Veronicastrum) extract exhibits excellent anti-inflammatory, anti-allergic and asthma-inhibitory activity, the animal experiments including: evaluation of inhibition of leukotriene production (Experimental Example 1); effects on the total number of cells in bronchoalveolar lavage (BAL) fluid by using male Balb/c mice (Experimental Example 2); effects on the number of neutrophil cells relative to the total number of cells in the BAL fluid (Experimental Example 3); effects on the number of Neutrophil+/Gr-1+ absolute cells in the BAL fluid (Experimental Example 4); effects on the number of CD11b+/Gr-1+ absolute cells from among lung cells (Experimental Example 5); effects on the number of CD4+/CD3+ absolute cells from among lung cells (Experimental Example 6); effects on the number of Macrophage+/CD11b+ absolute cells from among lung cells (Experimental Example 7); effects on the expression of inflammation factors in the BAL fluid (Experimental Example 8); and the like.

This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.